Los Altos, CA, United States of America

Mark D Bednarski

USPTO Granted Patents = 1 

 


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark D Bednarski: Innovator in Cyclic Nitro Compounds

Introduction

Mark D Bednarski is a notable inventor based in Los Altos, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on cyclic nitro compounds. His research focuses on developing treatments for various diseases characterized by abnormal cell proliferation.

Latest Patents

Mark D Bednarski holds a patent for "Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof." This invention provides cyclic nitro compounds and pharmaceutical compositions that can be utilized to treat or prevent diseases such as cancer, inflammation, cardiovascular disease, and autoimmune diseases. His work is crucial in advancing therapeutic options for these serious health conditions.

Career Highlights

Throughout his career, Mark has worked with prominent organizations, including Northrop Grumman Systems Corporation and Epicentrx, Inc. His experience in these companies has allowed him to develop his expertise in pharmaceutical innovations and contribute to significant advancements in medical science.

Collaborations

Mark has collaborated with various professionals in his field, including his coworker Susan Knox. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of new pharmaceutical solutions.

Conclusion

Mark D Bednarski's contributions to the field of cyclic nitro compounds highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for new treatments that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…